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1. Introduction 
The main goal in burn management has always been increasing the survival of severely 
burned patients by rapid debridement and early closure of burn wounds, consequently 
reducing the risk of infection, sepsis and multi-organ failure.  However, in the last decennia, 
surgical emphasis has shifted from survival to ‘quality of survival’, especially by improving 
the residual scars and preventing secondary contractures. Research and development of 
dermal skin substitutes has been directed towards improvement of scar quality by a bi-
layered reconstruction of dermis and epidermis. 
Allogeneic skin recovered from deceased donors is often used in the management of 
burns and other full thickness skin defects as a temporary coverage before definitive 
closure with autologous skin. Donor skin is used to improve the quality of the wound bed 
before grafting with autologous skin, as a biological dressing for partial thickness wounds 
(Hermans, 1989), or as overlay on widely expanded autograft (sandwich technique, Kreis 
et al., 1989). Excised full thickness defects treated with thin and widely expanded split 
thickness autografts often heal with an un-aesthetic, hypertrophic scar as final result as 
shown in figure 1. 
In patients with extensive burns it is not possible to use thicker autografts with limited 
expansion because of increased donor site morbidity. These results may improve if a dermal 
subsitute is placed underneath the split thickness skin graft. This substitute can replace the 
dermal tissue that is lost and provide a scaffold to the cells infiltrating in the wound bed 
during the healing process. The scaffold must be designed in such a way the cells will 
produce the new collagen fibers in a random organized structure, replacing slowly the 
scaffold material instead of making the typical parallel oriented fibers of scars (Van der 
Veen et al., 2010). In the past decades, several dermal substitutes products have become 
available but the clinical evidence on the effectiveness is limited until now (Brusselaers et 
al., 2010).  These commercially available products are based on animal derived collagen or 
human skin and associated with high costs (Jones et al., 2002). 
www.intechopen.com
 
Skin Grafts – Indications, Applications and Current Research 
 
292 
 
Fig. 1. Typical scar formation results after sandwich grafting, the mesh of the autologous 
skin graft pattern is still visible. 
2. Development of dermal substitute 
Dermal substitutes can be obtained from animal or human tissue as well as synthetic 
materials. The advantage of human skin is the presence of the natural collagen- elastin fibre 
network, providing the optimal three dimensional fibre structure for  ingrowing fibroblast 
and blood vessels. Antigenic structures must be absent from the dermal substitute to avoid 
the induction of inflammatory processes that can worsen final scar quality. Human 
allogeneic skin has been applied to the wound as dermal substitute in the past as described 
by Cuono et al., 1987.  In this method, the more immunogenic epidermis was removed 
several days after grafting the human donor skin and replaced by autogous cultured 
epithelial sheets. Technically, this method is difficult and in the allogeneic dermis cells of the 
donor remain present that can induce inflammation after wound closure. Therefore, several 
methods have been developed to remove the donor cells and hairs from the donor skin. This 
resulted in products known as Alloderm, Surederm, Graft jacket using enzymes and freeze 
drying techniques.  
We have developed a cost-effective method to eliminate the antigenic structures by using 
low concentrations of sodium hydroxide (Richters et al. 2008). De-cellularization of glycerol 
85% preserved skin starts by rinsing out the glycerol, thereafter the skin is incubated in 
0.06M NaOH for 6 weeks. The NaOH solution is refreshed every week and finally 
neutralized. The acellular dermis is again preserved in glycerol 85%. This method avoids 
freezing which may damage the collagen and elastin fibers and, at the same time, it is very 
effective in washing out the donor cells and hairs. The prototypes, consisting of an intact, 
native collagen-elastin matrix obtained using the NaOH method were tested in a porcine 
model. Full thickness wounds of 4x4 cm were transplanted with the prototype and an 
autologous split skin graft meshed 1:3. Contraction of the wounds treated with this 
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prototype was significantly lower compared to the control wounds, transplanted with only 
autologous skin (Richters et al., 2008, Pirayesh et al., 2007 and 2008). The six weeks 
treatment with NaOH showed the best results. Further experiments showed a two stage 
procedure was more optimal with the take rate of the autologous skin > 90% if the interval 
between application of the prototype and the autologous skin was 7 days. Final result with 
respect to contraction was comparable to Integra in this porcine model but the scar was 
more smooth (Pirayesh et al., 2011, manuscript  in preparation). This encouraging results let 
to the first pilot of clinical experiments on burn patients.  
3. Clinical application of Glyaderm 
This novel dermal substitute is called Glyaderm, which is an abbreviation for Glycerol-
preserved Acellular Dermis. Before application of Glyaderm, the wound bed must show 
viable granulation tissue. In most cases, woundbed preparation with allogeneic donor skin 
is needed; in burns this takes about 7 days after debridement.  Glyaderm is preserved in  
 
 
 
 
Fig. 2. Example of Glyaderm 
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85% glycerol and must be rinsed in sterile 0.9% NaCl before use on the patient. The 
Glyaderm is meshed 1:1 to allow drainage of wound fluid. Glyaderm was used on the 
patients also in a two stage procedure in clinical studies, approved by the local ethics 
committee of the University of Ghent, Belgium. A pilot study and a comparative study were 
performed sofar. 
4. Pilot study 
In the first non-randomized pilot experiments 15 patients with full thickness burns (TBSA < 
40%) were selected to study the optimal wound dressing,  to avoid dehydration and 
bacterial contamination of the Glyaderm during the first days before the autologous skin 
was applied. Then a group of 10 patients with full thickness wounds was selected (5 with 
burns and 5 with reconstructive wounds) and was treated to define the optimal time 
between the two operations using Laser Doppler Imaging. The depth of the burn wounds 
was first assessed using laser Doppler imaging (Monstrey et al., 2007) to assure the wounds 
were deep dermal. The patients were recruited and treated with Glyaderm and split 
thickness skin graft after wound bed preparation with glycerol preserved allografts.  Patient 
demographics were recorded and Laser Doppler imaging was used to monitor the 
vascularization of glyaderm. We also discovered that Laser Doppler Imaging allows us to 
measure wound tissue perfusion and monitor daily ingrowth of blood vessels into the 
dermal substitute. This allows us to know the exact timeframe in which the dermal bed is 
vascularised enough and skin grafting can be carried out. This is typically after 5-7 days, 
much shorter than the period necessary for ingrowth of the currently most widely used 
commercial dermal substitute Integra (Dantzer et al., 2001) 
4.1 Randomised, controlled, paired, intra-individual Comparative study in 30 patients 
After completing the pilot studies, a comparative study was performed. Patients with full 
thickness burns or full thickness lower arm defects after free flap harvesting were recruited.  
Part of the wounds were treated with Glyadem and split thickness skin and the other part 
with split thickness skin only. This was done in anatomically related areas to allow paired, 
intra-individual comparison of the wound healing. Preferably, a left/right comparison was 
made and the experimental treatment was randomized. Patient demographics were 
recorded and at regular follow up time points of 1, 3, 6 and 12 months after wound closure 
biopsies were taken and objective and subjective scar assessment was performed. The 
dermatospectrometer was used to measure scar colour, Dermalab cutometer for pliability 
and the modified Vancouver scar scale as well as a contour scale (Brusselaers et al 2010) 
were used. All data were recorded in a purpose designed database and subjected to 
statistical analysis with SPSS software package.  
5. Results of the pilot study 
All recruited patients responded well to a dressing regimen of surfasoft, a semipermeable 
membrane, with betadine gel and paraffin gauze in terms of bacterial control and 
prevention from desiccation of Glyaderm with capital. Laser Doppler Imaging proved to 
show enhanced vascularization from day 1 to day 5 allowing to exactly delineate the 
optimal engraftment interval. This was found to be 6 days with a 1 day standard deviation. 
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The increase in blood vessel growth can be observed clearly in Figure 3, the areas with a red 
color represent blood vessel flow and these are larger on day 7 in this patient. The take of 
the Glyaderm was > 90% and the take of the autologous skin > 95%. The results with respect 
to scar formation in this pilot study were encouraging. Figure 4 shows pictures of the 
wound and final scar of the same patient as in Figure 3. The color of the scar is not red and 
the patient is able to move the head normally, indicating good elasticity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Shows the growth of blood vessels in a deep burn wound treated with Glyaderm  
6. Results of the comparative study 
The take rates in the STSG on Glyaderm were comparable to the take rates in the wounds 
with a STSG alone (Wilcoxon Singed Ranks Test Z = -0.823, p = .41). Pliability and Visual 
Scores and contour scale assessment indicate a trend of improvement with Glyaderm 
treatments; however, follow-up times are currently too short with small numbers to be able 
to draw conclusions, we expect a necessary follow-up interval of two years. Comparing the 
Dermalab measurements for elasticity “Glyaderm + STSG” versus “STSG alone” statistics 
indicate that: Glyaderm + STSG” has significantly more elasticity when compared to “STSG 
alone” 1 month and 12 months after wound closure.  
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A: Burn wound before treatment 
 
 
B: Two years follow-up 
Fig. 4. Final results of this wound  with respect to scar formation  show a cosmetic good 
quality of the scar. 
7. Conclusion 
The results of the comparative, controlled, intra-individual clinical study show beneficial 
effects of a dermal substitute on the elasticity of the scar. The natural structure of the 
collagen and elastin fibers in glyaderm may have contributed to this effect. Glyaderm is the 
first non-commercial dermal substitute that can compete with all currently available dermal 
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equivalents. Laser Doppler imaging allows monitoring of vascular ingrowth in dermal 
substitutes such as Glyaderm. Although most burn experts advocate the use of dermal 
substitutes, the challenge remains to objectively show the perceived benefit over split 
thickness skin grafting alone. The evolving evaluation with objective scar assessment tools 
within these studies may help to demonstrate this benefit in the near future. 
Our next study with Glyaderm has started recently;  a multi-centre clinical study in 
major European Burn centers. To allow also quality of life and cost-effectiveness 
studies, 60 patients will be treated with glyaderm + STSG and 60 patients with STSG 
alone. 
Researchers continue their quest for the ideal skin substitute, and in the future it should be 
possible to create such an advanced skin substitute, containing melanocytes, hair follicles 
and sebaceous glands. The available products remain rather expensive, due to commercial 
incentives, high manufacturing costs, special shipment and storage conditions. 
Nevertheless, accelerated healing and closure of the wound will reduce the labour intensive 
dressing changes, hospital stay and the need for reconstructive surgery. Until the optimal 
off the shelve skin substitute becomes available, the burn surgeon can improve aesthetic and 
functional outcome by choosing from the gamut of currently available scaffolds for 
bilayered skin restoration. Glyaderm may well be an optimal cost-effective solution to 
bridge this gap in the near future. 
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The procedure of skin grafting has been performed since 3000BC and with the aid of modern technology has
evolved through the years. While the development of new techniques and devices has significantly improved
the functional as well as the aesthetic results from skin grafting, the fundamentals of skin grafting have
remained the same, a healthy vascular granulating wound bed free of infection. Adherence to the recipient bed
is the most important factor in skin graft survival and research continues introducing new techniques that
promote this process. Biological and synthetic skin substitutes have also provided better treatment options as
well as HLA tissue typing and the use of growth factors. Even today, skin grafts remain the most common and
least invasive procedure for the closure of soft tissue defects but the quest for perfection continues.
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